CY1107331T1 - Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης - Google Patents

Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης

Info

Publication number
CY1107331T1
CY1107331T1 CY20021100045T CY021100045T CY1107331T1 CY 1107331 T1 CY1107331 T1 CY 1107331T1 CY 20021100045 T CY20021100045 T CY 20021100045T CY 021100045 T CY021100045 T CY 021100045T CY 1107331 T1 CY1107331 T1 CY 1107331T1
Authority
CY
Cyprus
Prior art keywords
solid steel
solution standard
steel solution
standard standards
effervescent
Prior art date
Application number
CY20021100045T
Other languages
English (en)
Inventor
Wolfram Tritthart
Mario Andre Piskernig
Original Assignee
Meda Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma Gmbh & Co. Kg filed Critical Meda Pharma Gmbh & Co. Kg
Publication of CY1107331T1 publication Critical patent/CY1107331T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

Η εφεύρεση σχετίζεται με αναβράζουσες συνθέσεις ταχείας διάλυσης για στοματική εφαρμογή, που περιέχουν κετιριζίνη ή τα φαρμακευτικώς συμβατά άλατα αυτής, μία αναβράζουσα βάση που αποτελείται από τουλάχιστον ένα οργανικό, βρώσιμο οξύ και/ή τα άλατα αυτού, ανθρακικά ή όξινα ανθρακικά άλατα αλκαλίων ή αλκαλικών γαιών και προαιρετικά φαρμακευτικώς ανεκτά πρόσθετα.
CY20021100045T 1998-03-31 2002-03-04 Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης CY1107331T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
EP99922050A EP1067904B1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (1)

Publication Number Publication Date
CY1107331T1 true CY1107331T1 (el) 2012-12-19

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20021100045T CY1107331T1 (el) 1998-03-31 2002-03-04 Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης

Country Status (31)

Country Link
US (1) US6245353B1 (el)
EP (1) EP1067904B1 (el)
JP (1) JP2002509873A (el)
KR (1) KR100653568B1 (el)
CN (1) CN1136838C (el)
AR (1) AR018828A1 (el)
AT (1) ATE209899T1 (el)
AU (1) AU750140B2 (el)
BG (1) BG64741B1 (el)
BR (1) BR9909233A (el)
CA (1) CA2326809C (el)
CY (1) CY1107331T1 (el)
CZ (1) CZ300704B6 (el)
DE (2) DE19814256A1 (el)
DK (1) DK1067904T3 (el)
ES (1) ES2168013T3 (el)
HK (1) HK1036217A1 (el)
HU (1) HU227477B1 (el)
IL (1) IL138606A (el)
NO (1) NO329071B1 (el)
NZ (1) NZ506988A (el)
PL (1) PL191266B1 (el)
PT (1) PT1067904E (el)
RU (1) RU2216318C2 (el)
SI (1) SI1067904T1 (el)
SK (1) SK284476B6 (el)
TR (1) TR200002809T2 (el)
TW (1) TWI233808B (el)
UA (1) UA57615C2 (el)
WO (1) WO1999049843A1 (el)
ZA (1) ZA200005134B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008640B2 (en) * 2000-07-17 2006-03-07 Yamanouchi Pharmaceutical Co., Ltd. Pharmaceutical composition for oral use with improved absorption
EP1467715B1 (en) * 2002-01-15 2010-11-03 Ucb Farchim S.A. Formulations for oral administration of active compounds
DE60319685T2 (de) * 2002-04-04 2009-03-26 Pfizer Products Inc., Groton Wohlschmeckende kautablette
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CA2566384C (en) * 2004-05-28 2010-08-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PT2486942T (pt) 2004-11-24 2019-01-18 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
EP1954298A4 (en) 2005-11-28 2012-10-31 Imaginot Pty Ltd DISPENSING SYSTEM FOR ORAL THERAPEUTIC CONNECTION
US8383632B2 (en) * 2008-09-05 2013-02-26 Mcneil-Ppc, Inc. Method for making cetirizine tablets
CA2755543A1 (en) * 2009-03-13 2010-09-16 Nucitec S.A. De C.V. Compositions and methods for treatment and prevention of cardiovascular disease
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
WO2013188483A1 (en) 2012-06-12 2013-12-19 The Procter & Gamble Company Effervescent dosage form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
EP3799864B1 (en) 2019-10-02 2023-03-01 Intas Pharmaceuticals Limited Essentially sodium-free effervescent solid pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
UA34430C2 (uk) * 1991-05-13 2001-03-15 Дзе Бутс Компані Плс S(-)-2-(4-ізобутилфеніл)пропіонат натрію дигідрат, придатний для лікування запалення, болю і гіпертермії, фармацевтична композиція на його основі та спосіб одержання s(-)-2-(4-ізобутилфеніл)пропіонату натрію
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
CA2146637C (en) * 1992-10-09 2001-02-13 James Grigg Upson Pharmaceutical compositions and methods for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
EP0624364B1 (de) * 1993-04-15 1996-07-24 Gerhard Dr. Gergely Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
EP0695175A1 (en) * 1993-04-30 1996-02-07 The Procter & Gamble Company Coated pharmaceutical compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
DE59900501D1 (de) 2002-01-17
RU2216318C2 (ru) 2003-11-20
AU750140B2 (en) 2002-07-11
NO20004722D0 (no) 2000-09-21
SK14312000A3 (sk) 2001-07-10
TWI233808B (en) 2005-06-11
EP1067904A1 (de) 2001-01-17
AU3925399A (en) 1999-10-18
CZ300704B6 (cs) 2009-07-22
BG64741B1 (bg) 2006-02-28
TR200002809T2 (tr) 2000-12-21
PL191266B1 (pl) 2006-04-28
CA2326809C (en) 2008-11-18
DE19814256A1 (de) 1999-10-07
IL138606A (en) 2005-07-25
NZ506988A (en) 2002-05-31
ZA200005134B (en) 2000-12-21
KR100653568B1 (ko) 2006-12-05
ES2168013T3 (es) 2002-05-16
KR20010034718A (ko) 2001-04-25
US6245353B1 (en) 2001-06-12
HK1036217A1 (en) 2001-12-28
HUP0102676A2 (hu) 2001-11-28
NO329071B1 (no) 2010-08-16
CA2326809A1 (en) 1999-10-07
CZ20003481A3 (en) 2001-05-16
JP2002509873A (ja) 2002-04-02
CN1295464A (zh) 2001-05-16
HU227477B1 (en) 2011-07-28
AR018828A1 (es) 2001-12-12
EP1067904B1 (de) 2001-12-05
IL138606A0 (en) 2001-10-31
ATE209899T1 (de) 2001-12-15
SK284476B6 (sk) 2005-04-01
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
PL343199A1 (en) 2001-07-30
DK1067904T3 (da) 2002-04-02
BG104843A (en) 2001-07-31
CN1136838C (zh) 2004-02-04
BR9909233A (pt) 2000-11-28
SI1067904T1 (en) 2002-04-30
WO1999049843A1 (de) 1999-10-07
HUP0102676A3 (en) 2002-12-28
UA57615C2 (uk) 2003-06-16

Similar Documents

Publication Publication Date Title
CY1107331T1 (el) Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης
TR199902587T2 (xx) Fumarik asid t�revlerinin kullan�lmas�.
PL356904A1 (en) Pharmaceutical compositions
ATE245351T1 (de) Eletrolytische synthese von peressigsäure
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
CY1107992T1 (el) Συνθεσεις πολυαμιδο-αμικου οξεος υδατικης βασεως
ATE304346T1 (de) Zink enthaltende zahnpasta zusammensetzungen
BR9902086A (pt) Formulações farmacêuticas.
MXPA03007650A (es) Solucion de ester glicolico de acido softalico.
ES2571779T3 (es) Inhibidores de cinasa a base de nicotinamida
BRPI0017067B8 (pt) inibidor de divisão de célula, desidrogenase, método para a produção de um inibidor de divisão de célula e composto
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
CY1107681T1 (el) Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων
IT1302682B1 (it) Composizioni farmaceutiche orali contenenti buprenorfina
CA2372986A1 (en) Process for the condensation of polyamides
CY1106633T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
EA200101150A1 (ru) Раствор прукалоприда для перорального применения
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
HK1053472A1 (en) C10 carbonate substituted taxanes as antitumor agents.
PT1262186E (pt) Composicoes de antibioticos azalido
NO984162D0 (no) 5,11-dihydrobenzo(b,e)(1,4)oksazepinderivater og farmasöytiske sammensetninger inneholdende de samme
TR200100906T2 (tr) Trombin inhibitörleri olarak benzamid türevleri
CY1105987T1 (el) Παραγωγα πυριδινο-2-υλο-μεθυλαμινης για την θepαπεια της εξαρτησης απο τα οπιοειδη